Skip to main content
. 2019 Aug 29;10(4-6):161–167. doi: 10.1007/s12672-019-00367-0

Fig. 1.

Fig. 1

Overall survival for patients treated with systemic therapy for metastatic disease (N = 36). Blue bars indicate 95% confidence interval. The median OS from time of treatment initiation for metastatic disease was 18.7 months (95% CI 9.3–26.0)